Rishi Naik was born and raised in Chattanooga, Tennessee, and graduated summa cum laude from the University of Tennessee at Chattanooga. He has been lucky to call Vanderbilt his home since 2009. He graduated Alpha Omega Alpha from Vanderbilt Medical School, completed internship and residency at Vanderbilt, and was selected as Vanderbilt’s chief fellow for his gastroenterology fellowship. During his time as a fellow, he completed the Master in Science and Clinical Investigation (MSCI) program, which has provided a framework for enhancing clinical research and better patient care. In his third year of fellowship, he was selected to serve as the editorial fellow for Gastroenterology, an in-depth role in the editorial and publication process of high-impact manuscripts. He is a rare Quintuple Dore for his training at Vanderbilt.
His research interests involve novel therapies for patients with esophageal disease, including understanding the etiology and treatment of achalasia, eosinophilic esophagitis, and extraesophageal reflux disease. In collaboration with Vanderbilt’s Imaging Mass Spectrometry team and Vanderbilt’s Pathology Division, his group has discovered novel dysregulated proteins and lipids in the pathogenesis of achalasia. Building on this work, he is also evaluating patient genetic sequencing and phenomics to correlate with proteomic research and physiological patient data. By better understanding the etiologies of diseases, Dr. Naik hopes to personalize treatment based on symptoms and diagnosis to provide the correct therapy to fit all patients’ needs.